Fractalkine: moving from chemotaxis to neuroprotection
- 1 July 2006
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Neuroscience
- Vol. 9 (7), 859-861
- https://doi.org/10.1038/nn0706-859
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Control of microglial neurotoxicity by the fractalkine receptorNature Neuroscience, 2006
- Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic rootProceedings of the National Academy of Sciences, 2004
- Parkinson's DiseaseNeuron, 2003
- The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesionBlood, 2003
- Novel anti-inflammatory therapy for Parkinson's diseaseTrends in Pharmacological Sciences, 2003
- Production and neuroprotective functions of fractalkine in the central nervous systemBrain Research, 2003
- NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's diseaseProceedings of the National Academy of Sciences, 2003
- Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survivalProceedings of the National Academy of Sciences, 2000
- A new class of membrane-bound chemokine with a CX3C motifNature, 1997
- Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase MutationScience, 1994